Yamashita T, Iwase H, Yamashita i, Iwata H, Ito K, Toyama T, Hara Y, Kobayashi S
Second Department of Surgery, Nagoya City University Medical School, 1 Kawasumi, Mizuho-ku, Nagoya 467, Japan.
Breast Cancer. 1996 Dec 20;3(3):167-172. doi: 10.1007/BF02966980.
To investigate the possible involvement of the BRCA1 gene in Japanese sporadic breast cancer we have analyzed loss of heterozygosity (LOH) at the BRCA1 region (17q12-q22) in 101 sporadic breast cancers using 5 microsatellite markers, such as D17S250, D17S846, D17S855, D17S579, and NME1. The frequency of LOH in each markers was 14.9%(11/74), 11.9 %(8/67),14.3%(12/84),5.3%(4/75), and13.3%(9/68),respectively. The incidence of LOH in at least one of 5 markers was 23.8%(24/101). The LOH at the BRCA1 region did not significantly correlate with clinicopathologic factors. Despite using a microdissection method, the LOH frequency in our series was relatively lower than other reports, especially in Western countries. We suggest that the BRCA1 gene might play only a limited role as a tumor suppressor gene in the majority of Japanese sporadic breast cancers.
为了研究BRCA1基因在日本散发性乳腺癌中可能的作用,我们使用5个微卫星标记,如D17S250、D17S846、D17S855、D17S579和NME1,分析了101例散发性乳腺癌中BRCA1区域(17q12 - q22)的杂合性缺失(LOH)情况。每个标记的LOH频率分别为14.9%(11/74)、11.9%(8/67)、14.3%(12/84)、5.3%(4/75)和13.3%(9/68)。5个标记中至少有一个出现LOH的发生率为23.8%(24/101)。BRCA1区域的LOH与临床病理因素无显著相关性。尽管采用了显微切割方法,但我们研究系列中的LOH频率相对低于其他报告,尤其是西方国家的报告。我们认为,在大多数日本散发性乳腺癌中,BRCA1基因作为肿瘤抑制基因可能仅起有限作用。